GLP-1 receptor agonist — diabetes and cardiovascular risk reduction
Generic name: semaglutide (injection)
US Retail Price
$900–$1,000/month
With copay card: As low as $25/month (commercially insured)
Manufacturer
Novo Nordisk
Used For
Type 2 diabetes, cardiovascular risk reduction in patients with type 2 diabetes and established CVD
Ozempic is approved for type 2 diabetes and cardiovascular risk reduction — NOT for weight loss (that is Wegovy, which contains the same molecule at a higher dose). Generic semaglutide is not yet available. Compounded semaglutide from 503B pharmacies was available during the shortage period but FDA has ended the shortage designation.
Novo Nordisk offers a savings card that can reduce Ozempic to as low as $25/month for eligible commercially insured patients. Not valid for Medicare/Medicaid.
Apply for Ozempic Savings CardVerified international pharmacies sell Ozempic for significantly less than US retail. Ozempic is widely available in Canada and Europe at much lower prices.
Compare International PricesNovo Nordisk offers the Patient Assistance Program (PAP) for patients who meet income requirements. Medicare patients who cannot afford Ozempic should apply.
Search Ozempic PAP on NeedyMedsGoodRx coupons are available for Ozempic. Savings vary by pharmacy — check GoodRx for the current lowest price near you.
Check GoodRx PriceLooking for another medication?
The Med Map covers all 8 categories of savings options for hundreds of drugs.
Back to The Med Map